Drum May 2, 2022
The psychedelic industry could revolutionize mental healthcare. Compounds like MDMA and psilocybin are rapidly being pushed through clinical trials and have already been embraced by numerous cities and states across the US. With the psychedelics gold rush upon us, experts are warning about the need for marketers to prioritize sober education over intoxicating profit.
After more than half a century of propaganda-fueled demonization, psychedelics are slowly but surely being embraced by the mainstream. Now, profiteers are rushing in, eager to capitalize on a burgeoning market which could be valued at more than $10bn by 2027. There are some who worry that the drive for profit, coupled with irresponsible marketing practices, could eclipse safety measures — with potentially disastrous consequences,...
Today's Sponsors
Today's Sponsor